[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

 Anakinra

Product Approval Information - Licensing Action


Proper name: Anakinra
Tradename: Kineret
Manufacturer: Amgen, Inc, Thousand Oaks, CA, License #1080
Indication for Use: Reduction in signs and symptoms of moderately to severely active rheumatoid arthritis, in patients 18 years of age or older who have failed one or more disease modifying antirheumatic drugs (DMARDS)
Approval Date: 11/14/2001
Type of submission: Biologics license application


Approval Letter - (Text), (PDF)

Label - (PDF)

Patient Label - (PDF)


Last Updated: 11/16/2001

 

Back to Top     Back to Index

Date created: September 16, 2003

horizonal rule